NFKB1 and neoplasm: Apple oligogalactan combined with 5‐FU treatment effectively suppressed NF‐κB activation by inhibiting the degradation and phosphorylation of IκB to block the translocation of NF‐κB (p65) and enhanced the tumor suppressive effect of 5‐FU.